Sandrine Dudoit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sandrine Dudoit has a total of 450 co-authors. Here are the top co-authors by number of shared publications:
- Partow Imani
Division of Biostatistics, School of Public Health, University of California, Berkeley, California
63 shared publications - Stephen M. Rappaport
School of Public Health, University of California, Berkeley, California
48 shared publications - Paolo Vineis
School of Public Health, Imperial College , London
46 shared publications - Carlotta Sacerdote
Department of Health Sciences, University of Eastern Piedmont, Via Solaroli 17, 28100 Novara, Italy
45 shared publications - Giovanna Masala
Istituto Zooprofilattico Sperimentale “G. Pegreffi” della Sardegna, Via Duca degli Abruzzi 8, 07100 Sassari, Italy
45 shared publications - Hasmik Grigoryan
School of Public Health, University of California, Berkeley, California
45 shared publications
Latest Publications
- Open Access
Evolving stem cell fate capacities and transcriptional priming in the developing olfactory epithelium
The olfactory epithelium of adult mammals contains two populations of stem cells that support its remarkable ability to regenerate neuronal and non-neuronal cell types throughout life. How olfactory epithelial cell types are established during development, however, is not well understood. Here, we use genetic lineage tracing and single-cell RNA sequencing of the perinatal mouse olfactory epithelium to construct a developmental trajectory consisting of multiple lineages. We identify transitional states and lineage relationships between individual cells and establish Ascl1 + cells as the primary multipotent progenitors in the perinatal olfactory epithelium. Further, Ascl1 + cells become progressively restricted in their cell fate capacity over developmental time and appear to be transcriptionally primed toward specific lineages. We also predict signaling pathways that may contribute to lineage plasticity and niche permissiveness. Together, these results contribute to our understanding of how cell-intrinsic and -extrinsic signals contribute to the establishment of a stem cell niche.
Open AccessEvolving stem cell fate capacities and transcriptional priming in the developing olfactory epithelium
The olfactory epithelium of adult mammals contains two populations of stem cells that support its remarkable ability to regenerate neuronal and non-neuronal cell types throughout life. How olfactory epithelial cell types are established during development, however, is not well understood. Here, we use genetic lineage tracing and single-cell RNA sequencing of the perinatal mouse olfactory epithelium to construct a developmental trajectory consisting of multiple lineages. We identify transitional states and lineage relationships between individual cells and establish Ascl1 + cells as the primary multipotent progenitors in the perinatal olfactory epithelium. Further, Ascl1 + cells become progressively restricted in their cell fate capacity over developmental time and appear to be transcriptionally primed toward specific lineages. We also predict signaling pathways that may contribute to lineage plasticity and niche permissiveness. Together, these results contribute to our understanding of how cell-intrinsic and -extrinsic signals contribute to the establishment of a stem cell niche.
- Open Access
Unlocking Multi-Sample Differential Expression for Spatial Transcriptomics Data with TESSERA
Spatial transcriptomics allows the unprecedented examination of gene expression levels at the resolution of spatially-situated single cells in a high-throughput manner. As the technology is adopted more broadly, studies frequently collect data from multiple tissue samples, which leads to unique challenges that traditional spatial statistical methods are not equipped to handle. In particular, factors that differ across samples, such as different coordinate systems, different numbers and types of cells, different underlying tissue architectures, among others, preclude the application of traditional methods to our new setting. In this work, we propose a novel method, TESSERA, based on a spatial generalized linear model, for analyzing multi-sample spatial transcriptomics count data. Importantly, we provide a mathematical and computational framework for efficient and scalable model fitting and statistical inference to accompany the specification of our model. Our method for fitting the model enables the estimation of a common set of fixed effects across samples. This allows us to address a variety of differential expression questions, such as identification of which genes are differentially expressed between conditions (e.g., diseases, treatments), while accounting for spatial correlation between cells within a sample. We benchmark our proposed method on simulated data and apply it to a spatial transcriptomics dataset of human kidney samples. We find that our method provides a hitherto nonexistent extension to the multi-sample setting while remaining competitive with or outperforming existing algorithms in the single-sample setting.
Open AccessUnlocking Multi-Sample Differential Expression for Spatial Transcriptomics Data with TESSERA
Spatial transcriptomics allows the unprecedented examination of gene expression levels at the resolution of spatially-situated single cells in a high-throughput manner. As the technology is adopted more broadly, studies frequently collect data from multiple tissue samples, which leads to unique challenges that traditional spatial statistical methods are not equipped to handle. In particular, factors that differ across samples, such as different coordinate systems, different numbers and types of cells, different underlying tissue architectures, among others, preclude the application of traditional methods to our new setting. In this work, we propose a novel method, TESSERA, based on a spatial generalized linear model, for analyzing multi-sample spatial transcriptomics count data. Importantly, we provide a mathematical and computational framework for efficient and scalable model fitting and statistical inference to accompany the specification of our model. Our method for fitting the model enables the estimation of a common set of fixed effects across samples. This allows us to address a variety of differential expression questions, such as identification of which genes are differentially expressed between conditions (e.g., diseases, treatments), while accounting for spatial correlation between cells within a sample. We benchmark our proposed method on simulated data and apply it to a spatial transcriptomics dataset of human kidney samples. We find that our method provides a hitherto nonexistent extension to the multi-sample setting while remaining competitive with or outperforming existing algorithms in the single-sample setting.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Table S1: Cancer types and morphology codes
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Table S1: Cancer types and morphology codes
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Table S4: Variance components, ICCs and CVs for logged peak areas
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Table S4: Variance components, ICCs and CVs for logged peak areas
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Methods S1 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Methods S1: Detailed nLC-HRMSMS methods
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods S1 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Methods S1: Detailed nLC-HRMSMS methods
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Figure S1: Ensemble of classification models for selection of adduct features associated with NHL incidence
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Figure S1: Ensemble of classification models for selection of adduct features associated with NHL incidence
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Figure S2: Plots of ln(case/matched-control fold change) versus time to diagnosis (ttd) in days from recruitment for adduct features selected for MALES and FEMALES
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Figure S2: Plots of ln(case/matched-control fold change) versus time to diagnosis (ttd) in days from recruitment for adduct features selected for MALES and FEMALES
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Table S2: Cys34 and Lys525 adducts detected
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Table S2: Cys34 and Lys525 adducts detected
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Table S3: Fold changes and p-values for adducts
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Table S3: Fold changes and p-values for adducts
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Table S5: Features selected for association with NHL
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation
Supplementary Table S5: Features selected for association with NHL